News: HESRI

Combination approach to advanced cancer could improve survival

An international team of researchers, including experts from the University of Adelaide, has found genomic testing and targeted therapies for patients with advanced cancer could improve survival rates by up to 40 per cent.

[Read more about Combination approach to advanced cancer could improve survival]